Todd Stahl
Todd Stahl serves as the Vice President of Plasma Production at SAB, having worked with Tc Bovine project for over 20 years. Prior to joining SAB in 2014, Todd was the president of Hematech GAC Venture, LLC, a joint venture between Hematech and Trans Ova Genetics, which oversaw the care and development of Tc Bovine. In his current role, Todd oversees the Tc Bovine platform from the development and growth of the Tc Bovine to the maximization of plasma production for the use in SAB BIO’s clinical trials. His role is also responsible for assisting Regulatory Affairs in maintaining regulatory compliance from the USDA and plays a crucial role in maintaining SAB BIO’s AAALAC accreditation.
Before working on the Tc Bovine project, Todd worked in the Animal Health Industry in the research and development of vaccines and pharmaceuticals for companion animals and livestock. He has also worked as a consultant to international agribusiness spending time in eastern Europe and Madagascar. He studied at South Dakota State University and the University of Minnesota, earning a M.S. from the University of Minnesota in Dairy Management Systems.